TMDX is currently covered by 6 analysts with average potential upside of $8.55 (31.76%) backed by 29 price targets and 63 ratings. Documented since 28-May-2019. Analyst's average stock valuation to be materialised ratio is 89.68% with an average time for price targets to be met of 180.33 days.
Most recent stock forecast was given by CECILIA FURLONG from MORGAN STANLEY on 23-Feb-2023.
Highest price target for TMDX is 78, Lowest price target is 13, average price target is 45.5.
Currently, out of the existing stock ratings of TMDX - 22 which are a Buy (56.41%), 17 which are a Hold (43.59%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
74
$-0.71 (-0.95%)
63
1 months 4 days ago
13/15 (86.67%)
$2.39 (11.16%)
87
Buy
75
$0.29 (0.39%)
70
1 months 4 days ago
13/13 (100%)
$9.84 (39.63%)
235
Buy
85
$10.29 (13.77%)
45
1 months 4 days ago
6/7 (85.71%)
$10.31 (39.36%)
245
Buy
78
$3.29 (4.40%)
63
1 months 4 days ago
11/11 (100%)
$24.38 (85.07%)
296
Hold
48
$-26.71 (-35.75%)
12
7 months 25 days ago
4/5 (80%)
$1.78 (2.90%)
23
What is TMDX(TransMedics Group, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on TMDX(TransMedics Group, Inc) with a proven track record?
